Exciting news! #RSV season is coming up soon. Back in July, the U.S. FDA approved a new drug, nirsevimab, to protect newborns from respiratory syncytial virus, or RSV. It’s approved for use in all infants, even healthy infants born full-term. Read the full article below!

Posted by Leigh Ann at Hand to Hold at 2023-08-31 14:00:00 UTC